Mount Sinai Cardiovascular Doctors to Receive Honors During American College of Cardiology 70th Annual Scientific Session
Two of Mount Sinai’s top cardiovascular physicians will be recognized for their achievements at the American College of Cardiology’s 70th Annual Scientific Session, taking place virtually from Saturday, May 15, through Monday, May 17.
William Whang, MD, Associate Professor of Medicine (Cardiology), and Gilbert Tang, MD, MSc, MBA, Associate Professor of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai, are receiving the 2021 Simon Dack Awards for their exceptional contributions to the Journal of the American College of Cardiology (JACC) for their peer reviews. This journal ranks among the top cardiovascular journals in the world for its scientific impact.
The Simon Dack Award is named for the founding editor of JACC and recognizes outstanding peer reviewers who assist the journal in its mission of publishing important new clinical information. Dr. Whang and Dr. Tang are among five physicians to earn this distinguished honor for 2021.
“I am grateful to contribute to such an important journal as JACC and appreciate the opportunity to learn from the high-quality exciting research that is so often submitted,” says Dr. Whang.
“It was a pleasant surprise and is a true honor to be recognized for my participation with JACC and the American College of Cardiology on their academic mission,” says Dr. Tang.
Dr. Whang is Director of Clinical Electrophysiology Research at The Mount Sinai Hospital. He is a practicing cardiac electrophysiologist who specializes in catheter ablation procedures and implantation of pacemakers/defibrillators and left atrial appendage closure devices. Dr. Whang has active research interests in catheter ablation and new device technologies for patients with cardiac arrhythmia. In 2020 he reviewed 19 manuscripts for JACC and its family of journals. He has published more than 100 manuscripts in journals including Circulation, JAMA, and JACC, as well as chapters in major cardiology textbooks including Hurst’s The Heart. He is a Fellow of the American Heart Association, the Heart Rhythm Society, and the New York Academy of Medicine.
Dr. Gilbert Tang is the Surgical Director of the Structural Heart Program for Mount Sinai and specializes in transcatheter valve interventions including transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (MitraClip), transcatheter mitral valve replacement (TMVR) and transcatheter tricuspid valve repair (TriClip). He pioneered a technique to help better orient a transcatheter heart valve during TAVR to make it easier to re-access the coronary arteries. Dr. Tang has active research interests in TAVR and transcatheter mitral and tricuspid valve therapies. In 2020, he reviewed nearly 20 manuscripts for JACC and its family of journals. He has published nearly 150 original research articles, invited letters and editorials, and review articles in top medical journals including JAMA, JACC, Circulation, JAMA Cardiology, JACC: Cardiovascular Interventions, JACC: Cardiovascular Imaging, Circulation Cardiovascular Interventions, and has presented at many international conferences including ACC, AHA, TCT, TVT, EuroPCR, and PCR London Valves. He is currently involved in several multicenter studies with leading institutions in the United States and globally, including being the principal co-investigator in the international EXPLANT-TAVR and CUTTING-EDGE registries.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in 4 out of 10 pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.